Oxford Biodynamics jumps on interim findings from ongoing CiRT trial
4th Sep 2025 09:37
(Sharecast News) - Oxford BioDynamics said on Thursday that interim results from its ongoing FDA-registered PROWES trial demonstrated that its EpiSwitch CiRT test had a significant impact on treatment decisions for cancer patients receiving immune checkpoint inhibitors.
Read moreOxford BioDynamics enters collaboration with Google Cloud
13th Aug 2025 13:43
(Sharecast News) - Oxford BioDynamics announced a collaboration with Google Cloud on Wednesday, to accelerate the development and deployment of its cloud-based analytical framework for precision medicine.
Read moreOxford BioDynamics gets UK lab accredited as clinical facility
9th May 2025 12:30
(Sharecast News) - Oxford BioDynamics announced on Friday that its Oxford-based laboratory had been accredited by the UK Accreditation Service (UKAS) as a clinical facility under ISO 15189, enabling it to process 'EpiSwitch' clinical tests in the UK.
Read moreOxford BioDynamics signs distribution deal with Romania healthcare provider
12th Feb 2025 11:32
(Sharecast News) - Oxford BioDynamics announced on Wednesday that it has signed a distribution agreement with Regina Maria, Romania's largest private healthcare provider, to offer its EpiSwitch PSE and CiRT blood tests to physicians and patients across the country.
Read moreOxford BioDynamics upbeat on publication of EpiSwitch study
5th Feb 2025 12:34
(Sharecast News) - Oxford BioDynamics announced the publication of a multi-institutional clinical study on Wednesday, confirming the accuracy of its EpiSwitch Colorectal No-Stool Test (NST) in detecting colorectal cancer and precancerous polyps using a blood sample.
Read moreOxford BioDynamics raises £7.35m through placing, subscription and retail offer
17th Jan 2025 12:18
(Sharecast News) - Oxford BioDynamics, a precision clinical diagnostics company leveraging its 'EpiSwitch 3D' genomics platform, announced the successful completion of its fundraising initiative on Friday.
Read moreOxford Biodynamics CEO resigns as it seeks short-term funding
16th Dec 2024 10:50
(Sharecast News) - Clinical diagnostics specialist Oxford BioDynamics announced on Monday that Dr Jon Burrows had resigned from his positions as chief executive officer and board member, with immediate effect.
Read moreDirector dealings: Oxford Biodynamics director lowers stake
20th Oct 2023 15:32
(Sharecast News) - Oxford Biodynamics revealed on Friday that Vulpes Testudo Fund had offloaded 777,000 ordinary shares in the AIM-listed biotechnology company.
Read moreOxford BioDynamics secures US billing code for prostate test
3rd Oct 2023 10:41
(Sharecast News) - Precision test developer Oxford BioDynamics has successfully secured a proprietary laboratory analysis (PLA) code from the American Medical Association's (AMA) Current Procedural Terminology (CPT) Editorial Board, it announced on Tuesday.
Read moreOxford Biodynamics first-half losses widen
30th May 2023 07:48
(Sharecast News) - Oxford BioDynamics reported revenue of £0.22m in its first half on Tuesday, up from £0.09m in the same period a year earlier.
Read moreOxford Biodynamics raises £9.1m in placing
7th Oct 2022 12:57
(Sharecast News) - Biotech company Oxford BioDynamics said on Friday that it has conditionally raised around £9.1m in a placing to accelerate the commercialisation of a cancer test.
Read moreOxford BioDynamics awarded $0.91m US PACT grant
31st Aug 2021 12:48
(Sharecast News) - Oxford BioDynamics has been awarded an FNIH Partnership for Accelerating Cancer Therapies (PACT) grant, it announced on Tuesday, to use its 'EpiSwitch' diagnostic platform for the accurate prediction of a patient's response to immune checkpoint inhibitors (ICIs) from a routine blood sample.
Read moreOxford Biodynamics inks agreement with Agilent Technologies for EpiSwitch kit
31st Mar 2021 08:05
(Sharecast News) - Biotechnology company Oxford BioDynamics has signed a supply and resale agreement with US firm Agilent Technologies for the manufacture and sale of its new EpiSwitch Explorer Array Kit.
Read moreOxford BioDynamics names Matthew Wakefield as chairman
14th Dec 2020 09:29
(Sharecast News) - Biotechnology company Oxford BioDynamics appointed a new chairman on Monday.
Read moreOxford BioDynamics losses widen in first half
16th Jun 2020 13:15
(Sharecast News) - Biotechnology company Oxford BioDynamics reported a fall in revenue to £0.2m in its interim results on Tuesday, from £0.6m a year earlier.
Read more